FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yvette Torrens

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Concepts & Ideas

Kinetics

Co-author Network

Publications

TOP 3
Christophe Lanteri; Sandra Jimena Hernández Vallejo; Lucas Salomon; Emilie Lucie Doucet; Gérard Godeheu; Yvette Torrens; Vanessa Houades; Jean-Pol Tassin
Inhibition of monoamine oxidases desensitizes 5-HT1A autoreceptors and allows nicotine to induce a neurochemical and behavioral sensitization.
Christophe Lanteri; Lucas Salomon; Yvette Torrens; Jacques Glowinski; Jean-Pol Tassin
Drugs of abuse specifically sensitize noradrenergic and serotonergic neurons via a non-dopaminergic mechanism.
Jean-Pol Tassin; Yvette Torrens; Lucas Salomon; Christophe Lanteri; Philip Seeman
Elevated dopamine D2High receptors in alpha-1b-adrenoceptor knockout supersensitive mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yvette Torrens (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Christophe Lanteri; Sandra Jimena Hernández Vallejo; Lucas Salomon; Emilie Lucie Doucet; Gérard Godeheu; Yvette Torrens; Vanessa Houades; Jean-Pol Tassin
Inhibition of monoamine oxidases desensitizes 5-HT1A autoreceptors and allows nicotine to induce a neurochemical and behavioral sensitization.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009;29(4):987-97.
2008: Christophe Lanteri; Lucas Salomon; Yvette Torrens; Jacques Glowinski; Jean-Pol Tassin
Drugs of abuse specifically sensitize noradrenergic and serotonergic neurons via a non-dopaminergic mechanism.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(7):1724-34.
2007: Jean-Pol Tassin; Yvette Torrens; Lucas Salomon; Christophe Lanteri; Philip Seeman
Elevated dopamine D2High receptors in alpha-1b-adrenoceptor knockout supersensitive mice.
Synapse (New York, N.Y.) 2007;61(7):569-72.
2006: Sylvie Bretin; Véronique Rogemond; Philippe Marin; Marion Maus; Yvette Torrens; Jérôme Honnorat; Jacques Glowinski; Joël Prémont; Christian Gauchy
Calpain product of WT-CRMP2 reduces the amount of surface NR2B NMDA receptor subunit.
Journal of neurochemistry 2006;98(4):1252-65.
2006: Marion Maus; Yvette Torrens; Christian Gauchy; Sylvie Bretin; Angus Nairn; Jacques Glowinski; Joel Premont
2-Deoxyglucose and NMDA inhibit protein synthesis in neurons and regulate phosphorylation of elongation factor-2 by distinct mechanisms.
Journal of neurochemistry 2006;96(3):815-24.
2004: Jean-Claude Beaujouan; Yvette Torrens; Monique Saffroy; Marie-Louise Kemel; Jacques Glowinski
A 25 year adventure in the field of tachykinins.
Peptides 2004;25(3):339-57.
2003: Monique Saffroy; Yvette Torrens; Jacques Glowinski; Jean-Claude Beaujouan
Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites.
Neuroscience 2003;116(3):761-73.
2001: Philippe Marin; Laurent Fagni; Yvette Torrens; Gisèle Alcaraz; François Couraud; J Bockaert; Jacques Glowinski; Joël Prémont
AMPA receptor activation induces association of G-beta protein with the alpha subunit of the sodium channel in neurons.
The European journal of neuroscience 2001;14(12):1953-60.
2001: Monique Saffroy; Yvette Torrens; Jacques Glowinski; Jean-Claude Beaujouan
Presence of NK2 binding sites in the rat brain.
Journal of neurochemistry 2001;79(5):985-96.
2000: Jean-Claude Beaujouan; Monique Saffroy; Yvette Torrens; Jacques Glowinski
Different subtypes of tachykinin NK(1) receptor binding sites are present in the rat brain.
Journal of neurochemistry 2000;75(3):1015-26.
2000: Yvette Torrens; Jean-Claude Beaujouan; Monique Saffroy; Jacques Glowinski
Further evidence for the presence of "septide-sensitive" tachykinin binding sites in tissues possessing solely NK(1) tachykinin receptors.
Biochemical and biophysical research communications 2000;270(2):668-72.
1999: Jean-Claude Beaujouan; Monique Saffroy; Yvette Torrens; Sandrine Sagan; Jacques Glowinski
Pharmacological characterization of tachykinin septide-sensitive binding sites in the rat submaxillary gland.
Peptides 1999;20(11):1347-52.
1999: Alice Pébay; Yvette Torrens; Madeleine Toutant; Jocelyne Cordier; Jacques Glowinski; Martine Tencé
Pleiotropic effects of lysophosphatidic acid on striatal astrocytes.
Glia 1999;28(1):25-33.
1999: Sandrine Sagan; Laurent Venance; Yvette Torrens; Jocelyne Cordier; Jacques Glowinski; Christian Giaume
Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
The European journal of neuroscience 1999;11(2):691-9.
1998: Yvette Torrens; Jean-Claude Beaujouan; Monique Saffroy; Jacques Glowinski; Martine Tencé
Functional coupling of the NK1 tachykinin receptor to phospholipase D in chinese hamster ovary cells and astrocytoma cells.
Journal of neurochemistry 1998;70(5):2091-8.
1997: Sandrine Sagan; Jean-Claude Beaujouan; Yvette Torrens; Monique Saffroy; Gérard Chassaing; Jacques Glowinski; Solange Lavielle
High affinity binding of [3H]propionyl-[Met(O2)11]substance P(7-11), a tritiated septide-like peptide, in Chinese hamster ovary cells expressing human neurokinin-1 receptors and in rat submandibular glands.
Molecular pharmacology 1997;52(1):120-7.
1997: Yvette Torrens; Monique Saffroy; Jacques Glowinski; Jean-Claude Beaujouan
Substance P(6-11) and natural tachykinins interact with septide-sensitive tachykinin receptors coupled to a phospholipase C in the rat urinary bladder.
Neuropeptides 1997;31(3):243-51.
1997: Jean-Claude Beaujouan; Monique Saffroy; Yvette Torrens; Jacques Glowinski
Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801.
European journal of pharmacology 1997;319(2-3):307-16.
1995: Yvette Torrens; Jean-Claude Beaujouan; Monique Saffroy; Jacques Glowinski
Involvement of septide-sensitive tachykinin receptors in inositol phospholipid hydrolysis in the rat urinary bladder.
Peptides 1995;16(4):587-94.
1994: Thierry Galli; F Artaud; Yvette Torrens; Gérard Godeheu; M Desban; Jacques Glowinski; A Chéramy
NMDA and carbachol but not AMPA affect differently the release of [3H]GABA in striosome- and matrix-enriched areas of the rat striatum.
Brain research 1994;649(1-2):243-52.
1994: H Josien; Solange Lavielle; A Brunissen; Monique Saffroy; Yvette Torrens; Jean-Claude Beaujouan; Jacques Glowinski; Gérard Chassaing
Design and synthesis of side-chain conformationally restricted phenylalanines and their use for structure-activity studies on tachykinin NK-1 receptor.
Journal of medicinal chemistry 1994;37(11):1586-601.
1994: Monique Saffroy; Jean-Claude Beaujouan; François Petitet; Yvette Torrens; Jacques Glowinski
Differential localization of 3H-[Pro9]SP binding sites in the guinea pig and rat brain.
Brain research 1994;633(1-2):317-25.
1993: François Petitet; Monique Saffroy; Yvette Torrens; Jacques Glowinski; Jean-Claude Beaujouan
A new selective bioassay for tachykinin NK3 receptors based on inositol monophosphate accumulation in the guinea pig ileum.
European journal of pharmacology 1993;247(2):185-91.
1993: François Petitet; Jean-Claude Beaujouan; Monique Saffroy; Yvette Torrens; V Fardin; Jacques Glowinski
NK-1 tachykinin receptor in rat and guinea pig brains: pharmacological and autoradiographical evidence for a species difference.
Peptides 1993;14(3):551-9.
1993: Jean-Claude Beaujouan; E Heuillet; François Petitet; Monique Saffroy; Yvette Torrens; Jacques Glowinski
Higher potency of RP 67580, in the mouse and the rat compared with other nonpeptide and peptide tachykinin NK1 antagonists.
British journal of pharmacology 1993;108(3):793-800.
1993: François Petitet; Jean-Claude Beaujouan; Monique Saffroy; Yvette Torrens; Jacques Glowinski
The nonpeptide NK-2 antagonist SR 48968 is also a NK-3 antagonist in the guinea but not in the rat.
Biochemical and biophysical research communications 1993;191(1):180-7.
1992: Gérard Chassaing; Solange Lavielle; A Brunissen; A Carruette; C Garret; François Petitet; Monique Saffroy; Jean-Claude Beaujouan; Yvette Torrens; Jacques Glowinski
[Pro9]SP and [pGlu6, Pro9]SP(6-11) interact with two different receptors in the guinea-pig ileum as demonstrated with new SP antagonists.
Neuropeptides 1992;23(2):73-9.
1992: François Petitet; Jean-Claude Beaujouan; Monique Saffroy; Yvette Torrens; Solange Lavielle; Gérard Chassaing; D Loeuillet; Jacques Glowinski
[A new tachykinin receptor revealed by substance P analogues in the guinea pig ileum].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1992;314(7):299-303.
1992: François Petitet; Monique Saffroy; Yvette Torrens; Solange Lavielle; Gérard Chassaing; D Loeuillet; Jacques Glowinski; Jean-Claude Beaujouan
Possible existence of a new tachykinin receptor subtype in the guinea pig ileum.
Peptides 1992;13(2):383-8.
1991: H Duplaa; Gérard Chassaing; Solange Lavielle; Jean-Claude Beaujouan; Yvette Torrens; Monique Saffroy; Jacques Glowinski; P D'Orléans Juste; D Regoli; A Carruette
Influence of the replacement of amino acid by its D-enantiomer in the sequence of substance P. 1. Binding and pharmacological data.
Neuropeptides 1991;19(4):251-7.
1991: Yvette Torrens; M Dietl; Jean-Claude Beaujouan; Jacques Glowinski
Inhibitory effects of substance P and carbachol on the saturable sodium-dependent uptake process of myo-inositol in rat parotid gland.
The Journal of pharmacology and experimental therapeutics 1991;258(2):639-46.
1991: Jean-Claude Beaujouan; B Teutsch; Monique Saffroy; François Petitet; Yvette Torrens; Jacques Glowinski
NK-1 receptors are the only class of tachykinin receptors found on mouse cortical astrocytes.
Peptides 1991;12(4):813-20.
1991: Gérard Chassaing; Solange Lavielle; D Loeuillet; P Robilliard; A Carruette; C Garret; Jean-Claude Beaujouan; Monique Saffroy; François Petitet; Yvette Torrens
Selective agonists of NK-2 binding sites highly active on rat portal vein (NK-3 bioassay).
Neuropeptides 1991;19(2):91-5.
1991: François Petitet; Jean-Claude Beaujouan; Monique Saffroy; Yvette Torrens; Gérard Chassaing; Solange Lavielle; J Besseyre; C Garret; A Carruette; Jacques Glowinski
Further demonstration that [Pro9]-substance P is a potent and selective ligand of NK-1 tachykinin receptors.
Journal of neurochemistry 1991;56(3):879-89.
1991: Yvette Torrens; M M Dietl; Jean-Claude Beaujouan; Jacques Glowinski
Myoinositol uptake in rat parotid gland. A selective bioassay for NK1 receptors.
Annals of the New York Academy of Sciences 1991;632():145-53.
1990: Jean-Claude Beaujouan; M C Daguet de Montety; Yvette Torrens; Monique Saffroy; M Dietl; Jacques Glowinski
Marked regional heterogeneity of 125I-Bolton Hunter substance P binding and substance P-induced activation of phospholipase C in astrocyte cultures from the embryonic or newborn rat.
Journal of neurochemistry 1990;54(2):669-75.
1990: Solange Lavielle; Gérard Chassaing; D Loeuillet; O Convert; Yvette Torrens; Jean-Claude Beaujouan; Monique Saffroy; François Petitet; L Bergström; Jacques Glowinski
Selective agonists of tachykinin binding sites.
Fundamental & clinical pharmacology 1990;4(3):257-68.
1989: M M Dietl; Yvette Torrens; Jean-Claude Beaujouan; Jacques Glowinski
Substance P-induced reduction in the initial accumulation of cytosolic myo-[3H]inositol in rat parotid acinar cells mediated by the NK1 tachykinin receptor.
Journal of neurochemistry 1989;53(5):1640-3.
1989: Yvette Torrens; M C Daguet De Montety; M el Etr; Jean-Claude Beaujouan; Jacques Glowinski
Tachykinin receptors of the NK1 type (substance P) coupled positively to phospholipase C on cortical astrocytes from the newborn mouse in primary culture.
Journal of neurochemistry 1989;52(6):1913-8.
1989: M el-Etr; Jocelyne Cordier; Yvette Torrens; Jacques Glowinski; Joël Prémont
Pharmacological and functional heterogeneity of astrocytes: regional differences in phospholipase C stimulation by neuromediators.
Journal of neurochemistry 1989;52(3):981-4.
1989: Yvette Torrens; M Dietl; Jean-Claude Beaujouan; Jacques Glowinski
[Reduction induced by substance P of the initial accumulation of myo(3H)inositol in acinar cells of the parotid gland in rats].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1989;309(8):295-9.
1988: M Murray; Monique Saffroy; Yvette Torrens; Jean-Claude Beaujouan; J Glowinski
Tachykinin binding sites in the interpeduncular nucleus of the rat: normal distribution, postnatal development and the effects of lesions.
Brain research 1988;459(1):76-92.
1988: Jean-Claude Beaujouan; Monique Saffroy; François Petitet; Yvette Torrens; Jacques Glowinski
Neuropeptide K, scyliorhinin I and II: new tools in the tachykinin receptor field.
European journal of pharmacology 1988;151(2):353-4.
1988: Monique Saffroy; Jean-Claude Beaujouan; Yvette Torrens; J Besseyre; L Bergström; Jacques Glowinski
Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain.
Peptides 1988;9(2):227-41.
1988: Solange Lavielle; Gérard Chassaing; Olivier Ploux; D Loeuillet; J Besseyre; S Julien; Andrée Marquet; O Convert; Jean-Claude Beaujouan; Yvette Torrens
Analysis of tachykinin binding site interactions using constrained analogues of tachykinins.
Biochemical pharmacology 1988;37(1):41-9.
1987: L Bergström; Jean-Claude Beaujouan; Yvette Torrens; Monique Saffroy; Jacques Glowinski; Solange Lavielle; Gérard Chassaing; Andrée Marquet; P D'Orleans-Juste; SB Dion
3H-neurokinin A labels a specific tachykinin-binding site in the rat duodenal smooth muscle.
Molecular pharmacology 1987;32(6):764-71.
1987: L Bergström; Jean-Claude Beaujouan; Yvette Torrens; Monique Saffroy; Jacques Glowinski
Sulfhydryl reagents have different effects on substance P and neurokinin B binding sites on cortical synaptosomes in the rat.
Neuropeptides 1987;9(2):151-9.
1987: Jacques Glowinski; Yvette Torrens; Monique Saffroy; L Bergström; Jean-Claude Beaujouan; Solange Lavielle; Olivier Ploux; Gérard Chassaing; Andrée Marquet
Tachykinin receptors in the CNS.
Progress in brain research 1987;72():197-203.
1987: L Bergström; Yvette Torrens; Monique Saffroy; Jean-Claude Beaujouan; Solange Lavielle; Gérard Chassaing; J L Morgat; Jacques Glowinski; Andrée Marquet
[3H]neurokinin B and 125I-Bolton Hunter eledoisin label identical tachykinin binding sites in the rat brain.
Journal of neurochemistry 1987;48(1):125-33.
1986: Yvette Torrens; Jean-Claude Beaujouan; Monique Saffroy; M C Daguet de Montety; L Bergström; Jacques Glowinski
Substance P receptors in primary cultures of cortical astrocytes from the mouse.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(23):9216-20.
1986: Solange Lavielle; Gérard Chassaing; J Besseyre; Andrée Marquet; L Bergström; Jean-Claude Beaujouan; Yvette Torrens; Jacques Glowinski
A cyclic analogue selective for the NKB specific binding site on rat brain synaptosomes.
European journal of pharmacology 1986;128(3):283-5.
1986: Jean-Claude Beaujouan; Yvette Torrens; Monique Saffroy; J Glowinski
Quantitative autoradiographic analysis of the distribution of binding sites for [125I]Bolton Hunter derivatives of eledoisin and substance P in the rat brain.
Neuroscience 1986;18(4):857-75.
1986: Solange Lavielle; Gérard Chassaing; S Julien; Andrée Marquet; L Bergström; Jean-Claude Beaujouan; Yvette Torrens; Jacques Glowinski
Specific recognition of SP or NKB receptors by analogues of SP substituted at positions 8 and 9.
European journal of pharmacology 1986;125(3):461-2.
1985: Yvette Torrens; Jean-Claude Beaujouan; J Glowinski
Pharmacological characterisation of two tachykinin binding sites in the rat cerebral cortex.
Neuropeptides 1985;6(1):59-70.
1984: M Ninkovic; Jean-Claude Beaujouan; Yvette Torrens; Monique Saffroy; M D Hall; J Glowinski
Differential localization of tachykinin receptors in rat spinal cord.
European journal of pharmacology 1984;106(2):463-4.
1984: Solange Lavielle; Gérard Chassaing; Jean-Claude Beaujouan; Yvette Torrens; A Marquet
Binding affinities to rat brain synaptosomes--synthesis of biotinylated analogues of Substance P.
International journal of peptide and protein research 1984;24(5):480-7.
1984: C Poujade; Solange Lavielle; Yvette Torrens; Jean-Claude Beaujouan; J Glowinski; A Marquet
A peptidases-resistant glycosylated analogue of substance P-(5-11). Specificity towards substance P receptors.
Neuropeptides 1984;4(5):361-8.
1984: Jean-Claude Beaujouan; Yvette Torrens; A Viger; J Glowinski
A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative.
Molecular pharmacology 1984;26(2):248-54.
1984: Yvette Torrens; Solange Lavielle; Gérard Chassaing; A Marquet; J Glowinski; Jean-Claude Beaujouan
Neuromedin K, a tool to further distinguish two central tachykinin binding sites.
European journal of pharmacology 1984;102(2):381-2.
1983: Yvette Torrens; Jean-Claude Beaujouan; A Viger; J Glowinski
Properties of a 125I-substance P derivative binding to synaptosomes from various brain structures and the spinal cord of the rat.
Naunyn-Schmiedeberg's archives of pharmacology 1983;324(2):134-9.
1983: A Viger; Jean-Claude Beaujouan; Yvette Torrens; J Glowinski
Specific binding of a 125I-substance P derivative to rat brain synaptosomes.
Journal of neurochemistry 1983;40(4):1030-9.
1983: C Poujade; Solange Lavielle; Yvette Torrens; A Marquet
Synthesis and biological activity of glycosylated analogs of the C-terminal hexapeptide and heptapeptide of substance P.
International journal of peptide and protein research 1983;21(3):254-7.
1982: Jean-Claude Beaujouan; Yvette Torrens; A Herbet; M C Daguet; J Glowinski; A Prochiantz
Specific binding of an immunoreactive and biologically active 125I-labeled substance P derivative to mouse mesencephalic cells in primary culture.
Molecular pharmacology 1982;22(1):48-55.
1982: Yvette Torrens; R Michelot; Jean-Claude Beaujouan; J Glowinski; J Bockaert
In vivo biosynthesis of 35S-substance P from [35S]methionine in the rat striatum and its transport to the substantia nigra.
Journal of neurochemistry 1982;38(6):1728-34.
1982: J Glowinski; Yvette Torrens; Jean-Claude Beaujouan
The striatonigral substance P pathway and dopaminergic mechanisms.
Ciba Foundation symposium 1982;(91):281-95.
1981: Yvette Torrens; Jean-Claude Beaujouan; M J Besson; R Michelot; J Glowinski
Inhibitory effects of GABA, L-glutamic acid and nicotine on the potassium-evoked release of substance P in substantia nigra slices of the rat.
European journal of pharmacology 1981;71(4):383-92.
1980: R Michelot; H Gozlan; Jean-Claude Beaujouan; M J Besson; Yvette Torrens; J Glowinski
Synthesis and biological activities of substance P iodinated derivatives.
Biochemical and biophysical research communications 1980;95(2):491-8.